Modified bariatric surgery provides remission of Type 2 diabetes

June 25, 2012

(Medical Xpress) -- Type 2 diabetes often reverses after modified weight loss surgery, especially when the duration of diabetes is less than 10 years, a new study finds. The results will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

"Modified bariatric surgery such as sleeve gastrectomy should be considered at an earlier stage of , rather than as a last resort," said the senior investigator, Kirtikumar Modi, MD, an endocrinologist at Medwin Hospital, Hyderabad, India.

Sleeve gastrectomy is a less radical form of restrictive than gastric bypass, the most common type of bariatric surgery. It reduces the size of the stomach using laparoscopic ("keyhole") surgery and stomach stapling. Recent research shows that the procedure can resolve or greatly improve Type 2 diabetes in obese patients and even in some diabetic patients who are not obese.

Initially, Modi and co-workers studied 43 patients with Type 2 diabetes who had sleeve gastrectomy with ileal interposition, in which the ileum, a part of the small intestine, is moved closer to the stomach. All patients had poorly controlled diabetes, with an average disease duration of 10 years. On average, their (BMI) was 33 kg/m2.

After sleeve gastrectomy, 20 (47 percent) of the patients no longer had diabetes, at an average follow-up of 20 months, the authors reported. Remission of diabetes was defined as having a level (a measure of over the past three months) below 6.5 percent and no longer needing insulin or oral hypoglycemic agents (blood sugar-lowering medications). The other 23 patients in this group all needed fewer or smaller doses of oral , Modi said. Of the 30 patients who had before surgery, 27 (90 percent) no longer had hypertension after the operation, according to the study abstract.

Patients who had better improvement in diabetes remission and other metabolic abnormalities were those who had diabetes less than 10 years and a BMI above 27, the researchers found. When they excluded nonobese patients from analysis, the diabetes remission rate increased to 85 percent, similar to that reported with gastric bypass surgery, Modi said.

Based on these predictors of good outcomes, the researchers assigned 17 additional patients with Type 2 diabetes to undergo a different modification of bariatric surgery, called diverted sleeve gastrectomy. This laparoscopic procedure diverts food away from parts of the small intestine, including the duodenum, where absorption of nutrients begins. The patients received this procedure because, compared with the original group, they had a longer duration of diabetes—15 years on average—and a lower BMI (29 kg/m2), which predicted worse outcomes with sleeve gastrectomy, Modi explained.

An average of nine months after diverted sleeve gastrectomy, 12 patients, or more than 70 percent, had remission of diabetes. The investigators reported that the remaining five patients had decreased requirements for oral hypoglycemic medications. Seven of the eight patients (nearly 88 percent) who had high blood pressure before surgery no longer did postoperatively.

"Modified bariatric surgery promises to be an effective treatment for achieving a cure of Type 2 and other metabolic abnormalities like high blood pressure," Modi said.

Explore further: Study compares sleeve gastrectomy with medical treatment in obese patients with type 2 diabetes

Related Stories

Study compares sleeve gastrectomy with medical treatment in obese patients with type 2 diabetes

April 16, 2012
A study comparing a bariatric surgical procedure with conventional medical treatment in morbidly obese patients with type 2 diabetes mellitus suggests that surgery was associated with remission or improvement in diabetes-related ...

Weight-loss surgery provides benefit to high-risk, severely obese patients

May 3, 2012
Among surgeries for obesity, a newer, increasingly popular procedure called sleeve gastrectomy provides more weight loss to high-risk, severely obese patients than adjustable gastric banding, a new study suggests.

Type 2 diabetes cured by weight loss surgery returns in one-fifth of patients

June 25, 2012
A new study shows that although gastric bypass surgery reverses Type 2 diabetes in a large percentage of obese patients, the disease recurs in about 21 percent of them within three to five years. The study results will be ...

Scientists reassess weight loss surgery for type 2 diabetes

January 4, 2012
Weight loss surgery is not a cure for type 2 diabetes, but it can improve blood sugar control, according to a new study published in the British Journal of Surgery. Whereas some previous studies have claimed that up to 80 ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.